共 5 条
- [4] Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India (vol 22, pg 1052, 2022) LANCET INFECTIOUS DISEASES, 2023, 23 (02): : E47 - E47